"Diabetic Angiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Descriptor ID |
D003925
|
| MeSH Number(s) |
C14.907.320 C19.246.099.500
|
| Concept/Terms |
Diabetic Angiopathies- Diabetic Angiopathies
- Angiopathies, Diabetic
- Angiopathy, Diabetic
- Diabetic Angiopathy
- Diabetic Vascular Diseases
- Diabetic Vascular Disease
- Vascular Disease, Diabetic
- Vascular Diseases, Diabetic
- Diabetic Vascular Complications
- Diabetic Vascular Complication
- Vascular Complication, Diabetic
- Vascular Complications, Diabetic
Microangiopathy, Diabetic- Microangiopathy, Diabetic
- Diabetic Microangiopathies
- Diabetic Microangiopathy
- Microangiopathies, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Angiopathies".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Angiopathies".
This graph shows the total number of publications written about "Diabetic Angiopathies" by people in this website by year, and whether "Diabetic Angiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Angiopathies" by people in Profiles.
-
Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
-
Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2019 09 01; 4(9):857-864.
-
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
-
Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial. Cardiovasc Drugs Ther. 2018 10; 32(5):443-451.
-
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence. Diabetes Obes Metab. 2010 May; 12(5):384-92.
-
Improved clinical outcomes using a culturally sensitive diabetes education program in a Hispanic population. Diabetes Educ. 2008 Jul-Aug; 34(4):698-706.
-
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007 May-Jun; 13 Suppl 1:1-68.
-
Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int. 2006 Jul; 98(1):116-24.
-
Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
-
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.